奥拉西坦对脑卒中后认知功能障碍患者认知功能的影响

卞光亮; 张茜

doi:10.7619/jcmp.202016008

奥拉西坦对脑卒中后认知功能障碍患者认知功能的影响

卞光亮¹,
张茜²

江苏省连云港市第二人民医院, 1. 医保处, 2. 药剂科, 江苏连云港, 222006

详细信息

中图分类号: R743.3
计量
- 文章访问数: 458
- HTML全文浏览量: 154
- PDF下载量: 14
出版历程
- 收稿日期: 2020-06-18
- 网络出版日期: 2020-09-14

Effect of oxiracetam on cognitive function of patients with cognitive dysfunction after stroke

BIAN Guangliang¹,
ZHANG Qian²

1. Department of Medical Insurance, 2. Department of Pharmacy, The Second People's Hospital of Lianyungang City, Lianyungang, Jiangsu, 222006

摘要

摘要: 目的探讨奥拉西坦对脑卒中后认知功能障碍患者认知功能的影响。方法选取87例脑卒中后认知功能障碍患者,应用盲抽法分为对照组(n=43)与观察组(n=44)。对照组给予吡拉西坦治疗,观察组给予奥拉西坦治疗,比较2组临床疗效、认知功能、细胞因子水平及不良反应发生率。结果对照组总有效率为79.07%, 低于观察组的95.45%, 差异有统计学意义(P<0.05)。治疗后, 2组简易智力状况检查量表(MMSE)评分均较治疗前提高,且观察组高于对照组,差异均有统计学意义(P<0.05)。治疗后, 2组基质金属蛋白酶-3(MMP-3)、丙二醛(MDA)水平较治疗前降低,超氧化物歧化酶(SOD)水平较治疗前升高,且观察组MMP-3、MDA水平低于对照组, SOD水平高于对照组,差异有统计学意义(P<0.05)。观察组不良反应发生率为6.82%, 对照组为13.95%, 差异无统计学意义(P>0.05)。结论脑卒中后认知功能障碍患者采用奥拉西坦治疗效果显著,可有效改善机体细胞因子水平和患者认知功能,且安全性高。
- 脑卒中 /
- 认知功能障碍 /
- 奥拉西坦 /
- 基质金属蛋白酶 /
- 超氧化物歧化酶
Abstract: Objective To investigate the effect of oxiracetam on cognitive function of patients with cognition dysfunction after stroke. Methods Totally 87 patients with cognition dysfunction after stroke were divided into control group(n=43)and observation group(n=44)according to blind selection method. The control group was treated with piracetam, and the observation group was treated with oxiracetam. The clinical efficacy, cognitive function, levels of cytokines and the incidence of adverse reactions were compared between two groups. Results The total effective rate of the control group was 79.07%, which was significantly lower than 95.45% of the observation group(P<0.05). After treatment, the scores of Mini-mental State Examination(MMSE)in both groups were significantly higher than those before treatment, and the score of MMSE in the observation group was significantly higher than that in the control group(P<0.05). After treatment, the levels of matrix metalloproteinase-3(MMP-3)and malondialdehyde(MDA)in both groups were significantly lower than those before treatment, the level of superoxide dismutase(SOD)was significantly higher than that before treatment, the levels of MMP-3 and MDA in the observation group were significantly lower than those in the control group, and the level of SOD in the observation group was significantly higher than that in the control group(P<0.05). The incidence of adverse reactions in the observation group was 6.82%, which showed no significant difference when compared to 13.95% in the control group(P>0.05). Conclusion Oxiracetam is effective in the treatment of patients with cognitive dysfunction after stroke, which can effectively improve the cytokines level and cognitive function and it has a higher safety.
- stroke /
- cognitive dysfunction /
- oxiracetam /
- matrix metalloproteinase /
- superoxide dismutase

HTML全文

参考文献(12)

孙金菊, 陈长香, 张敏, 等. 言语听觉反馈训练对脑卒中患者认知功能障碍的康复效果[J]. 中华行为医学与脑科学杂志, 2017, 26(6): 524-528.

邵培宁, 秦荣荣, 尹彩霞, 等. 奥拉西坦治疗急性脑梗死认知功能的疗效[J]. 江苏医药, 2016, 42(19): 2174-2175.

WANG J, HU Z, YANG S, et al. Inflammatory cytokines and cells are potential markers for patients with cerebral apoplexy in intensive care unit[J]. Exp Ther Med, 2018, 16(2): 1014-1020.

中华医学会神经病分会脑血管病组. 中国急性缺血性脑卒中诊治指南[J]. 中华神经科杂志, 2010, 43(2): 2-3.

纪裕伟, 杨晓飞, 郭金礼, 等. 组织化卒中医疗对脑卒中患者NIHSS、GCS和ADL评分的影响及疗效研究[J]. 河北医药, 2019, 41(12): 1817-1820.

储新娟, 涂志兰, 金芃芃, 等. 缺血性脑卒中患者血管性认知功能障碍的现状及影响因素分析[J]. 中国临床医生杂志, 2017, 45(12): 43-44.

RONG Y, FENG S, WU C, et al. LC-high-resolution-MS/MS analysis of chemical compounds in rat plasma after oral administration of Nao-Mai-Tong and its individual herbs[J]. Biomed Chromatogr, 2017, 31(7): 156-158.

何培成, 许著一. 血清同型半胱氨酸、维生素B₁₂水平对急性缺血性脑卒中患者认知功能及预后的影响[J]. 实用临床医药, 2019, 23(24): 27-30.

雷敏, 吴丽荣, 刘英. 丁苯酞对脑卒中后抑郁患者血清同型半胱氨酸、神经细胞因子、单胺类递质和炎症因子的影响研究[J]. 陕西医学杂志, 2019, 48(7): 853-855.

吴红霞, 韩天明, 欧小凡, 等. 血清Th细胞因子在脑卒中后抑郁患者血清中的表达水平分析[J]. 临床和实验医学杂志, 2019, 18(17): 1841-1844.

FAN W, LI X, HUANG L, et al. S-oxiracetam ameliorates ischemic stroke induced neuronal apoptosis through up-regulating α7 nAChR and PI3K/Akt/GSK3β signal pathway in rats[J]. Neurochem Int, 2018, 115(7): 50-60.

王翔, 张铭, 唐卫华. 瓜蒌承气汤加减联合奥拉西坦治疗急性脑出血的临床研究[J]. 中西医结合心脑血管病杂志, 2019, 17(13): 1947-1950.